December 12, 2011
FDA Panel Cites Clot Risk From Contraceptive
PatchAn advisory panel to the
U.S. Food and Drug Administration on Friday said that the Ortho
Evra birth control patch carries a higher risk of blood clots for
women compared to older methods, but should not be taken off drug
store shelves.
Gene Therapy a Boon for 6 Hemophilia PatientsA single treatment of gene
therapy dramatically improved symptoms and quality of life in a
small group of men with hemophilia B, an uncommon form of the
bleeding disorder, a new study suggests.